XK
REGN icon

Xact Kapitalforvaltning’s Regeneron Pharmaceuticals REGN Stock Holding History

Xact Kapitalforvaltning’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$8.84M Buy
18,101
+210
+1% +$86.6K 0.19% 106
2019
Q4 		$6.72M Buy
17,891
+613
+4% +$206K 0.11% 169
2019
Q3 		$4.79M Buy
17,278
+1,566
+10% +$463K 0.09% 205
2019
Q2 		$4.92M Buy
15,712
+969
+7% +$323K 0.1% 189
2019
Q1 		$6.05M Buy
14,743
+321
+2% +$132K 0.14% 146
2018
Q4 		$5.39M Sell
14,422
-2,064
-13% -$755K 0.14% 142
2018
Q3 		$6.66M Sell
16,486
-825
-5% -$314K 0.14% 143
2018
Q2 		$5.97M Sell
17,311
-458
-3% -$143K 0.13% 157
2018
Q1 		$6.12M Sell
17,769
-3
-0% -$1.04K 0.14% 155
2017
Q4 		$6.68M Buy
17,772
+3,397
+24% +$1.38M 0.16% 132
2017
Q3 		$6.43M Buy
14,375
+402
+3% +$191K 0.18% 126
2017
Q2 		$6.86M Buy
13,973
+448
+3% +$196K 0.21% 109
2017
Q1 		$5.24M Buy
13,525
+354
+3% +$131K 0.16% 147
2016
Q4 		$4.83M Buy
13,171
+2,366
+22% +$900K 0.17% 131
2016
Q3 		$4.34M Buy
+10,805
New +$4.33M 0.15% 150

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Xact Kapitalforvaltning's REGN Position: Q1 2020 in Review

Xact Kapitalforvaltning increased its Regeneron Pharmaceuticals (REGN) stake by 1.2% in Q1 2020, buying an estimated $86.6K and bringing the position to 18,101 shares worth $8.84M. The position accounts for 0.19% of the portfolio, ranked #106.

Xact Kapitalforvaltning first reported a position in REGN in Q3 2016 and has held it in 15 quarters since. 817 funds tracked by Wall St. Rank hold REGN as of Q1 2020.

  • Xact Kapitalforvaltning held 18,101 shares of Regeneron Pharmaceuticals worth $8.84M as of Q1 2020.
  • Xact Kapitalforvaltning bought 210 Regeneron Pharmaceuticals shares in Q1 2020, an estimated $86.6K.
  • Regeneron Pharmaceuticals made up 0.19% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #106 holding.
  • Xact Kapitalforvaltning first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 15 quarters since.
  • 817 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.